Immunoproteasome Disrupts Neuronal Metabolism and Drives Neurodegeneration in Multiple Sclerosis
A groundbreaking study published in the journal Cell on August 21, 2025, reveals a critical mechanism underlying neurodegeneration in multiple sclerosis (MS). The research identifies the immunoproteasome as a key driver of neuronal damage, demonstrating that it significantly disturbs neuronal metabolism. This metabolic disruption accelerates the degeneration of nerve cells, contributing to the progressive disability observed in MS patients. By elucidating the specific role of the immunoproteasome in altering cellular metabolic pathways, the findings provide new insights into the pathophysiology of the disease. This discovery highlights potential therapeutic targets for preventing or slowing down neurodegeneration in MS, moving beyond traditional immune-focused treatments to address metabolic dysfunction within neurons. The study underscores the complex interplay between immune responses and neuronal health, offering a novel perspective on how chronic inflammation leads to permanent neural damage. These results are significant for the development of future interventions aimed at preserving neuronal function and improving long-term outcomes for individuals suffering from multiple sclerosis.
Wire timeline
Immunoproteasome Disrupts Neuronal Metabolism and Drives Neurodegeneration in Multiple Sclerosis
A groundbreaking study published in the journal Cell on August 21, 2025, reveals a critical mechanism underlying neurodegeneration in multiple sclerosis (MS). The research identifies the immunoproteasome as a key driver of neuronal damage, demonstrating that it significantly disturbs neuronal metabolism. This metabolic disruption accelerates the degeneration of nerve cells, contributing to the progressive disability observed in MS patients. By elucidating the specific role of the immunoproteasome in altering cellular metabolic pathways, the findings provide new insights into the pathophysiology of the disease. This discovery highlights potential therapeutic targets for preventing or slowing down neurodegeneration in MS, moving beyond traditional immune-focused treatments to address metabolic dysfunction within neurons. The study underscores the complex interplay between immune responses and neuronal health, offering a novel perspective on how chronic inflammation leads to permanent neural damage. These results are significant for the development of future interventions aimed at preserving neuronal function and improving long-term outcomes for individuals suffering from multiple sclerosis.
Cell